Linezolid and Mycamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linezolid (linezolid) and Mycamine (micafungin sodium). Common drug interactions include dermatitis exfoliative generalised among females and toxic epidermal necrolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Linezolid and Mycamine. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Linezolid?

Linezolid has active ingredients of linezolid. It is often used in infection. eHealthMe is studying from 21,891 Linezolid users. Check the latest studies of Linezolid.

What is Mycamine?

Mycamine has active ingredients of micafungin sodium. eHealthMe is studying from 2,237 Mycamine users. Check the latest studies of Mycamine.



On Jul, 10, 2026

50 people who take Linezolid and Mycamine together, and have interactions are studied.

Linezolid and Mycamine drug interactions.

What are the common drug interactions of Linezolid and Mycamine, by gender? *:

female:

  1. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  2. Rash morbilliform (a rash that looks like measles)
  3. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  4. Lung infection
  5. Pyrexia (fever)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Subcutaneous emphysema (smooth bulging of the skin)
  8. Leukopenia (less number of white blood cells in blood)
  9. Confusional state
  10. Deafness

male:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Lung disorder (lung disease)
  3. Septic shock (shock due to blood infection)
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Acute hepatic failure
  6. Drug resistance (reduction in effectiveness of a drug)
  7. Enterocutaneous fistula
  8. Hepatic failure (liver failure)
  9. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  10. Peripheral circulatory failure

What are the common drug interactions of Linezolid and Mycamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Staphylococcal infection (an infection with staphylococcus bacteria)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Enterocutaneous fistula
  3. Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total)

50-59:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Acute hepatic failure
  3. Drug resistance (reduction in effectiveness of a drug)
  4. Hepatic failure (liver failure)
  5. Intra-abdominal haemorrhage (intra-abdominal bleeding)
  6. Lung disorder (lung disease)
  7. Peripheral circulatory failure
  8. Thoracic haemorrhage (bleeding from chest cavity)
  9. Wound

60+:

  1. Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
  2. Rash morbilliform (a rash that looks like measles)
  3. Septic shock (shock due to blood infection)
  4. Leukopenia (less number of white blood cells in blood)
  5. Confusional state
  6. Deafness
  7. Hepatitis toxic
  8. Increased upper airway secretion
  9. Lethargy (tiredness)
  10. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 36 people, 72.00%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 38.00%
  3. Sepsis (a severe blood infection that can lead to organ failure and death): 16 people, 32.00%
  4. Candida Sepsis (candida in blood stream): 14 people, 28.00%
  5. Fistula (an abnormal connection or passageway between two): 13 people, 26.00%
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 8.00%
  7. Pain: 4 people, 8.00%
  8. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 8.00%
  9. Anaesthesia: 4 people, 8.00%
  10. Dry Eyes (lack of adequate tears): 4 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Linezolid and Mycamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Linezolid and Mycamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Linezolid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mycamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linezolid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on linezolid and micafungin sodium (the active ingredients of Linezolid and Mycamine, respectively), and Linezolid and Mycamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: